Luminal primary muscle-invasive bladder cancer patients are less likely to benefit from platinum-based neoadjuvant chemotherapy

被引：0
|
作者：
Boormans, J. L. [1 ]
De Jong, J. J. [1 ]
Liu, V. Y. T. [2 ]
Bismar, T. A. [3 ]
Boorjian, S. A. [4 ]
Huang, H-C. [2 ]
Davicioni, E. [5 ]
Mian, O. Y. [6 ]
Wright, J. L. [7 ]
Necchi, A. [8 ]
Dall'Era, M. [9 ]
Kaimakliotis, H. Z. [10 ]
Black, P. C. [11 ]
Gibb, E. A. [2 ]
Lotan, Y. [12 ]
机构：
[1] Erasmus MC, Dept Urol, Rotterdam, Netherlands
[2] Decipher Biosci, Dept Res, Vancouver, BC, Canada
[3] Univ Calgary, Dept Pathol & Lab Med, Calgary, AB, Canada
[4] Mayo Clin, Dept Urol, Rochester, MN USA
[5] Decipher Biosci, Dept Res, San Diego, CA USA
[6] Cleveland Clin, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA
[7] Univ Washington, Dept Urol, Seattle, WA 98195 USA
[8] Univ Vita Salute San Raffaele, Dept Med, Milan, Italy
[9] Univ Calif Davis, Dept Urol Surg, Davis, CA 95616 USA
[10] Indiana Univ, Dept Urol, Indianapolis, IN 46204 USA
[11] Univ British Columbia, Dept Urol Sci, Vancouver, BC, Canada
[12] Univ Texas Southwestern, Dept Urol, Dallas, TX USA
来源：
EUROPEAN UROLOGY | 2021年 / 79卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
P0830
引用
收藏
页码：S1156 / S1156
页数：1
相关论文
共 50 条
  • [11] Determinants of neoadjuvant chemotherapy use in muscle-invasive bladder cancer
    Carvalho, Filipe L. F.
    Zeymo, Alexander
    Egan, Jillian
    Kelly, Colleen H.
    Zheng, Chaoyi
    Lynch, John H.
    Hwang, Jonathan
    Stamatakis, Lambros
    Krasnow, Ross E.
    Kowalczyk, Keith J.
    INVESTIGATIVE AND CLINICAL UROLOGY, 2020, 61 (04) : 390 - 396
  • [12] Sarcopenia and Response to Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Lyon, Timothy D.
    Frank, Igor
    Takahashi, Naoki
    Boorjian, Stephen A.
    Moynagh, Michael R.
    Shah, Paras H.
    Tarrell, Robert F.
    Cheville, John C.
    Viers, Boyd R.
    Tollefson, Matthew K.
    CLINICAL GENITOURINARY CANCER, 2019, 17 (03) : 216 - +
  • [13] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Macleod, Liam C.
    Fam, Mina M.
    Yabes, Jonathan G.
    Hale, Nathan E.
    Turner, Robert M., II
    Lopa, Samia H.
    Gingrich, Jeffrey R.
    Borza, Tudor
    Skolarus, Ted A.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 201 - +
  • [14] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Zargar, Homayoun
    Espiritu, Patrick N.
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Gandhi, Nilay M.
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Youssef, David
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Black, Peter C.
    EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249
  • [15] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Vasdev, N.
    Zargar, H.
    Fairey, A.
    Espiritu, P.
    Krabbe, L.
    Mongomery, J.
    Gandhi, N.
    Griffin, J.
    Yu, E.
    Campain, N.
    Xylinas, E.
    Horenblas, S.
    Yousef, D.
    Kassouf, W.
    Shariat, S.
    Aning, J.
    Wright, J.
    Holzbeierlein, J.
    Bivalacqua, T.
    Morgan, T.
    North, S.
    Borcas, D.
    Lotan, Y.
    Shah, J.
    Spiess, P.
    Van Rhijn, B.
    Daneshmand, S.
    Black, P.
    Thorpe, A. C.
    BJU INTERNATIONAL, 2014, 113 : 25 - 25
  • [16] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer
    Clark, Peter E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 821 - 830
  • [17] COST EFFECTIVENESS ANALYSIS OF NEOADJUVANT CHEMOTHERAPY IN PATIENTS WITH MUSCLE-INVASIVE BLADDER CANCER
    Stevenson, Scott
    Deibert, Chris
    McKiernan, James
    JOURNAL OF UROLOGY, 2013, 189 (04): : E170 - E170
  • [18] LINC00857 expression predicts and mediates the response to platinum-based chemotherapy in muscle-invasive bladder cancer
    Dudek, Aleksandra M.
    van Kampen, Jasmijn G. M.
    Witjes, J. Alfred
    Kiemeney, Lambertus A. L. M.
    Verhaegh, Gerald W.
    CANCER MEDICINE, 2018, 7 (07): : 3342 - 3350
  • [19] Effectiveness of platinum-based adjuvant chemotherapy for muscle-invasive bladder cancer: A weighted propensity score analysis.
    Shimizu, Fumitaka
    Muto, Satoru
    Taguri, Masataka
    Ieda, Takeshi
    Okegawa, Takatsugu
    Yamaguchi, Raizo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [20] The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder Cancer
    Stecca, Carlos
    Mitin, Timur
    Sridhar, Srikala S.
    SEMINARS IN RADIATION ONCOLOGY, 2023, 33 (01) : 51 - 55
12345